NIH, NINR, and AHRQ Funding Opportunity Announcements
| Dates and Deadlines | Title | Summary Information |
|---|---|---|
|
FOA Number: RFA-NS-22-053 Earliest Submission Date: October 4, 2022 Letter of Intent Due: 30 days prior to application due date Expiration Date: November 5, 2022 |
NIH HEAL Initiative: Coordinated Approaches to Pain Care in Health Care Systems (UG3/UH3 - Clinical Trial Optional) |
The NIH has an FOA soliciting research applications that propose implementation science methodology to embed existing evidence-based coordinated pain care models into a variety of public and private health care systems (HCS) - where this type of care does not exist. Applications that combine comparative effectiveness studies of innovative coordinated care models with strong implementation science methodology to embed effective approaches into HCSs also are encouraged. This FOA solicits applications from HCS who have resources and infrastructure to support research and implementation of study approaches in partnership with those HCS who lack research resources or experience and would benefit most from implementation of cost-effective coordinated pain care. HCS partners who serve populations that are under-represented in research are encouraged to apply. |
|
Notice Number: NOT-NR-22-015 Estimated Publication Date of FOA: August 15, 2022 First Estimated Application Due Date: Nov. 15, 2022 Earliest Estimated Award/Start Date: July 1, 2023 |
NIH: NOI to Publish FOA for HEAL Initiative: Prevention and Management of Chronic Pain in Rural Populations (UG3/UH3, Clinical Trials Required) | The NIH HEAL (Helping to End Addiction Long-term) Initiative intends to promote a new initiative by publishing a FOA soliciting applications for UG3/UH3 phased cooperative research to accelerate implementation of effective, non-opioid interventions for chronic pain management in rural and remote populations. The overall goal of this initiative is to support the implementation of effective clinical practices and procedures that may lead to prevention or improved management of chronic pain in rural and/or remote populations, along with a reduction in unnecessary opioid prescribing and/or use. |
|
FOA Number: RFA-AG-23-024 Earliest Submission Date & Letter of Intent Due Date: September 20, 2022 |
This Funding Opportunity Announcement (FOA) solicits Research Project Grant (R01) applications for projects designed to exploit variations (e.g., geographic, temporal) in social and health care policies to employ experimental, quasi-experimental, or other innovative approaches to uncover mechanisms driving disparities in care (i.e., access, utilization, and quality) for persons living with Alzheimer’s disease and Alzheimer’s disease-related dementias (AD/ADRD). | |
|
RFA Release: anticipated June 13, 2022 Informational Webinar: June 29, 2022 @ 2pm ET. Register HERE Applications Due: September 1, 2022 @ 5pm ET. |
NIA: Notice of Intent to Publish FOA for IMPACT Career Development Awards |
The NIA IMPACT Collaboratory plans to publish a RFA for CDA Program. The IMPACT Collaboratory plans to fund up to 2 CDAs in this cycle. For more information, click HERE. RFA is expected to be published on June 13, 2022 on impactcollaboratory.org Questions related to this funding opportunity? Contact IMPACTcollaboratory@hsl.harvard.edu |
|
Notice Number: NOT-CA-22-077 Release Date: April 08, 2022 Estimated Publication Date of Funding Opportunity Announcement: May 27, 2022 First Estimated Application Due Date: September 01, 2022 Earliest Estimated Award Date: July 01, 2023 Earliest Estimated Start Date: July 30, 2023 |
The National Cancer Institute (NCI) intends to publish a new funding opportunity regarding the needs of individuals living with advanced cancer. |
|
|
Open Date: Sept. 10, 2021 Expires: Feb. 14, 2024 |
This Funding Opportunity Announcement (FOA) will support pragmatic trials within Stage IV of the NIH Stage Model to improve dementia care across multiple dementia care settings that will: (1) be designed to address practical comparative questions faced by Alzheimer’s disease (AD) and AD-related dementia (ADRD) patients, clinicians, and caregivers (both paid and unpaid); (2) include broad and diverse populations; and (3) be conducted in real-world settings with adequate sample size. These trials are intended to produce results that can be directly adopted by healthcare providers, patients, or caregivers for rapid dissemination and implementation. Successful applications will: (1) improve quality of care of persons with dementia; (2) improve quality of life for persons with dementia and their informal caregivers; (3) deliver more patient-focused, cost-effective care across multiple settings; and/or (4) reduce disparities in dementia care. This FOA will support Stage I or Stage III pilot research to test the feasibility of implementing and integrating interventions (R61 phase) that, if successful, can transition to an R33 phase (Stage IV) for implementation of large pragmatic trials. The transition from the R61 to the R33 phase of the award will be administratively reviewed and determined by successful completion of the go/no-go criteria that are specified for the R61 phase. |
|
|
Open Date: Sept. 10, 2021 Expires: Feb. 14, 2024 |
PAR-21-307: Dementia Care and Caregiver Support Intervention Research (R01 Clinical Trial Required) |
This Funding Opportunity Announcement (FOA) solicits mechanism-focused dementia care and caregiver support intervention development research at Stages I through V of the NIH Stage Model to address the care needs and promote the health, function, and well-being of persons with Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD) and of those providing their care. The NIH Stage Model offers a framework to: (1) support development of efficacious interventions that are defined by their principles; and (2) ensure that these efficacious interventions can be administered in the community or in health systems with fidelity to the intervention’s principles. This includes the development, testing, and validation of scalable training materials and procedures so that these interventions can be delivered with fidelity in community settings or health systems. Settings can include the home, community, or formal care settings, such as nursing homes, assisted living facilities, nursing and rehabilitation centers, hospitals, adult day care, and specialized hospice settings. The overarching purpose of this FOA is to help to lay the groundwork for real-world implementation of AD/ADRD care and caregiving interventions. The principle-based interventions under development may target behavioral, psychological, interpersonal, social, or institutional processes and may be designed for use at the individual, family, dyad, group, community, or health-systems level. Applications may propose mechanism-focused intervention research for individuals living with dementia or for individuals or systems providing care for people at any stage of AD/ADRD. Applications proposing the development of interventions that address the principles underlying the care needs and challenges for individuals from diverse racial, ethnic, and socioeconomic backgrounds are strongly encouraged. Applications that involve interdisciplinary expertise and translational expertise (e.g., basic behavioral, social, psychological, or neurobiological science expertise relevant to hypothesized intervention mechanisms; expertise in the AD/ADRD service delivery system; and clinical psychological science expertise in areas outside of aging or AD/ADRD, but potentially relevant to AD/ADRD caregiver research, etc.) are also strongly encouraged. Applications may propose to create, modify, and test AD/ADRD care and caregiver support interventions based upon hypothesized mechanisms of action and are encouraged to incorporate a test of essential components or mechanisms of change using an appropriate methodological approach. |
Other Funding and Training Opportunities
| Dates and Deadlines | Title | Summary Information |
|---|---|---|
|
Attendance is limited to 36 participants and will be based on a competitive application process. Members of the PCRC will be given some priority in the selection process. However, all research protocols must have an oncology focus. Physicians, nurses, social workers, and psychologists who are early-stage researchers are eligible to attend. Participants must have a doctoral degree. For more information and to apply, please visit https://pallcare.hms.harvard.edu/courses/rmso.
Applications are due by September 7, 2022. |
The Ninth Annual HARVARD MEDICAL SCHOOL WORKSHOP ON RESEARCH METHODS IN SUPPORTIVE ONCOLOGY (Jan 22-27, 2023) |
This intensive 6-day workshop will provide an overview of fundamental methods, such as study designs, qualitative and survey methods, and approaches to data analysis in supportive oncology research. Over the course of the workshop, participants will write a complete study protocol under the direct mentorship of expert faculty in the field of supportive oncology. Participants will continue to receive assistance after the workshop from their workshop mentors to help in the implementation of their studies at their home institutions. Essential workshop topics include: creation of conceptual models, supportive care clinical trials, development of psychosocial interventions, decision science, stakeholder engagement, web-based research, study of patient-provider communication, qualitative and survey methods, and data analysis. Jennifer Temel, MD and William Pirl, MD, MPH will co-chair the workshop with a multidisciplinary team of faculty including: Joseph Greer, PhD; Elyse Park, MD, MPH; Lara Traeger, PhD; Lisa Wood, PhD; James Tulsky, MD; Areej El-Jawahri, MD; Joanne Wolfe, MD, MPH and others. |
|
Rolling deadline Applications are due by December 1, 2022 for start dates in 2023.
|
University of Colorado Palliative Care and Aging Research Training (T32) |
Funded by a Ruth Kirschstein National Research Service Award NRSA T32 from the National Institute on Aging (NIA), this Program builds on the significant Palliative Care expertise and research opportunities within the University of Colorado. Participants become members of the community of scholars at the University of Colorado and are provided with the full array of resources available within the Department of Medicine and the Colorado Clinical & Translational Sciences Institute (CCTSI). More information about T32 opportunities at the University of Colorado Palliative Care Post-Doctoral |
|
Application Due Date: February 1st of desired start year Candidates will be selected on a rolling basis each year until each of the two new slots per year are filled. |
Weill Cornell Medicine Post-Doctoral Training Program in Behavioral Geriatrics (T32) |
This 2-year Postdoctoral Training Program in Behavioral Geriatrics develops independent investigators capable of conducting patient-oriented research to improve the quality of life and quality of care of older adults. The Program is co-led by Cary Reid, MD, PhD, Director of the Translational Research Institute on Pain in Later Life and Holly G. Prigerson, PhD, Director of the Center for Research on End-of-Life Care both based in the Department of Medicine, Division of Geriatrics and Palliative Medicine at Weill Cornell Medicine. Applications are accepted from both MD and PhD postdoctoral trainees (2/year) seeking careers at the intersection of biomedical and innovative social/behavioral approaches to improve care and care outcomes in older adults. Please see the links below for more information:
|
| Applications are accepted on a rolling basis for a variety of potential start dates |
Cambia Palliative Care Center of Excellence Palliative Care Research Fellowship Program |
Fellowships will be 1-3 years in duration. Trainees must have an interest in palliative care research related to heart, lung or blood disease. For more details and information about the Palliative Care Research Fellowship, please visit http://www.uwpalliativecarecenter.com |